ENTITY

Concert Pharmaceuticals (CNCE US)

3
Analysis
Health CareUnited States
Concert Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company offers medicines and other related drug products. Concert Pharmaceuticals serves patients in the United States.
more
Refresh
28 Feb 2023 19:52

Dr. Reddy's Laboratories (DRRD IN): New Acquisition to Bolster US Generic Product Portfolio

Dr. Reddy's is acquiring the US generic prescription product portfolio of Mayne Pharma for upfront cash consideration of up to $90M. The acquired...

Logo
273 Views
Share
20 Jan 2023 21:11

Sun Pharmaceutical Ind (SUNP IN): Acquisition Adds Late-Stage Biopharma Product in Derma Franchise

Sun Pharma is acquiring US-based Concert Pharmaceuticals for $576M. Post-acquisition, the priority will be to materialize Concert’s plan to submit...

Logo
468 Views
Share
bullishPfizer Inc
21 Jul 2022 18:29

Pfizer Inc (PFE US): What’s Lie Ahead of Comirnaty? Potential Blockbuster Drugs in Pipeline

By leveraging on windfall gains from COVID portfolio, Pfizer is developing additional growth spots for future revenue growth. Its pipeline and...

Logo
312 Views
Share
No more insights
x